files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
About US
Editors
Issues
Pages
Indexed in

Research Journal of Medical Sciences, Volume 18, Issue 10 (2024)

References

  1. Rajendran, S.N. and S.M. Gurusamy, 2019. Palmoplantar psoriasis: A comparative therapeutic study. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Res. Dermatol., Vol. 5. 10.18203/issn.2455-4529.intjresdermatol20194668 1-10.
  2. Engin, B., Ö. Aşkın and Y. Tüzün, 2017. Palmoplantar psoriasis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Clin. Dermatol., 35: 1-10.
  3. Spencer, R.K., K.G. Elhage, J.Q. Jin, M.S. Davis, M. Hakimi, T. Bhutani and W. Liao, 2023. Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Dermatol. Ther., 13: 1-10.
  4. Zhang, L., Y. Su, H. Shucheng, L. Wang and X. Jiang, 2024. Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Am. Acad. Dermatol., 90: 1-10.
  5. Carrascosa, J.M., A. Plana and C. Ferrándiz, 2013. Effectiveness and Safety of Psoralen-UVA (PUVA) Topical Therapy in Palmoplantar Psoriasis: A Report on 48 Patients. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Actas Dermo-Sifiliográficas, 104: 1-10.
  6. Gisondi, P., T. Gracia-Cazaña, H. Kurzen and J. Galván, 2024. Calcipotriol/Betamethasone Dipropionate for the Treatment of Psoriasis: Mechanism of Action and Evidence of Efficacy and Safety versus Topical Corticosteroids. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Clin. Med., Vol. 13. 10.3390/jcm13154484 1-10.
  7. Vakirlis, E., et al., 2008. Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ther. Clin. Risk Manage., 4: 1-10.
  8. Gold, L.S., K. Papp, D. Pariser, L. Green and N. Bhatia et al., 2022. Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Am. Acad. Dermatol., 86: 1-10.
  9. Broggi, G., M. Failla, A. Palicelli, M. Zanelli and R. Caltabiano, 2022. Palmoplantar Psoriasis: A Clinico-Pathologic Study on a Series of 21 Cases with Emphasis on Differential Diagnosis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Diagnostics, Vol. 12. 10.3390/diagnostics12123071 1-10.
  10. Wang, R.F., D. Ko, B.J. Friedman, H.W. Lim and T.F. Mohammad, 2023. Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Am. Acad. Dermatol., 88: 271-2880.
  11. Sarma, N., 2017. Evidence and suggested therapeutic approach in psoriasis of difficult-to-treat areas: Palmoplantar psoriasis, nail psoriasis, scalp psoriasis, and intertriginous psoriasis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Indian J. Dermatol., 62: 1-10.
  12. Samarasekera, E.J., L. Sawyer, D. Wonderling, R. Tucker and C.H. Smith, 2013. Topical therapies for the treatment of plaque psoriasis: Systematic review and network meta-analyses. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Br. J. Dermatol., 168: 1-10.